Assessment of Denosumab in Korean Postmenopausal Women with Osteoporosis: Randomized, Double-Blind, Placebo-Controlled Trial with Open-Label Extension

PURPOSE: The efficacy and safety of denosumab was compared with placebo in Korean postmenopausal women with osteoporosis in this phase III study. MATERIALS AND METHODS: Women aged 60 to 90 years with a T-score of <-2.5 and ≥-4.0 at the lumbar spine or total hip were randomized to a single 60 mg s...

Descripción completa

Detalles Bibliográficos
Autores principales: Koh, Jung-Min, Chung, Dong Jin, Chung, Yoon-Sok, Kang, Moo-Il, Kim, In-Ju, Min, Yong-Ki, Oh, Han-Jin, Park, Il Hyung, Lee, Yil-Seob, Kravitz, Barbara, Waterhouse, Brian, Nino, Antonio, Fitzpatrick, Lorraine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951467/
https://www.ncbi.nlm.nih.gov/pubmed/27189284
http://dx.doi.org/10.3349/ymj.2016.57.4.905

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951467/
https://www.ncbi.nlm.nih.gov/pubmed/27189284
http://dx.doi.org/10.3349/ymj.2016.57.4.905

Ejemplares similares